|
|
|
Insider
Information: |
Baker Bros Advisors Llc |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
287,772 |
|
Indirect Shares
|
13,789,697 |
|
|
Direct
Value |
$59,327,707 |
|
|
Indirect Value
|
$1,262,987,005 |
|
|
Total
Shares |
14,077,469 |
|
|
Total
Value |
$1,322,314,712 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2012-06-19 |
0 |
2012-06-19 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-11-21 |
288 |
2013-06-05 |
860,515 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2013-05-17 |
154,001 |
2013-05-17 |
326,648 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
|
0 |
2013-10-24 |
40,308 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2014-06-20 |
1,520 |
2014-06-20 |
367,326 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2016-05-11 |
131,963 |
2016-05-11 |
6,198,972 |
Premium* |
|
Kymera Therapeutics, Inc. |
KYMR |
|
|
0 |
2024-03-28 |
5,995,928 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
Director |
|
2012-06-19 |
4 |
D |
$32.00 |
$221,257,312 |
I/I |
(6,914,291) |
0 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-06-05 |
4 |
B |
$35.82 |
$7,799,540 |
I/I |
217,773 |
301,215 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-13 |
4 |
B |
$34.02 |
$7,291,166 |
I/I |
213,242 |
282,523 |
2.25 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
|
2013-10-24 |
4 |
B |
$17.50 |
$7,000,000 |
I/I |
400,000 |
40,308 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-11-20 |
4 |
B |
$26.83 |
$6,143,360 |
I/I |
229,000 |
271,800 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-06-04 |
4 |
B |
$36.62 |
$5,993,193 |
I/I |
163,659 |
296,480 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-06-03 |
4 |
B |
$36.69 |
$4,708,433 |
I/I |
128,341 |
292,922 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2014-04-23 |
4 |
OE |
$65.10 |
$3,645,600 |
I/I |
56,000 |
219,614 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-28 |
4 |
B |
$36.93 |
$2,742,933 |
I/I |
74,266 |
287,997 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-24 |
4 |
B |
$36.93 |
$2,308,909 |
I/I |
62,517 |
286,384 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-02-11 |
4 |
B |
$28.23 |
$2,258,084 |
I/I |
79,984 |
274,991 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-15 |
4 |
B |
$36.41 |
$1,898,361 |
I/I |
52,133 |
284,241 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-31 |
4 |
B |
$36.75 |
$1,883,256 |
I/I |
51,242 |
290,132 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2014-06-20 |
4 |
OE |
$60.45 |
$1,798,388 |
I/I |
29,750 |
223,864 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-29 |
4 |
B |
$36.82 |
$1,730,615 |
I/I |
47,000 |
289,018 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-02-08 |
4 |
B |
$27.96 |
$1,017,106 |
I/I |
36,376 |
273,249 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-02-14 |
4 |
B |
$28.43 |
$989,402 |
I/I |
34,800 |
276,124 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-14 |
4 |
B |
$35.53 |
$965,899 |
I/I |
27,184 |
283,112 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-02-21 |
4 |
B |
$27.63 |
$779,359 |
I/I |
28,200 |
277,189 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-16 |
4 |
B |
$36.54 |
$705,426 |
I/I |
19,306 |
284,659 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-05-23 |
4 |
B |
$36.18 |
$623,799 |
I/I |
16,900 |
285,026 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-02-20 |
4 |
B |
$27.97 |
$584,220 |
I/I |
20,885 |
276,577 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2013-02-13 |
4 |
B |
$28.58 |
$491,585 |
I/I |
17,200 |
275,366 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-11-21 |
4 |
B |
$27.54 |
$8,262 |
I/I |
300 |
271,806 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2013-05-17 |
4 |
A |
$0.00 |
$0 |
I/I |
10,500 |
326,648 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|